RATIONALE: Walnut syrup is produced from the sap of walnut trees and is an emerging gourmet food product. While the production of walnut syrup does not include processing of the walnut kernel, the allergenicity of walnut syrup in individuals with a known tree nut allergy to walnuts is unknown. We hypothesize that walnut syrup is not allergenic to individuals with a documented tree nut allergy to walnuts. METHODS: To determine if the walnut allergenic protein is found in walnut syrup, we first measured protein levels using ELISA in walnut syrup samples. We next recruited nine individuals with history and skin-test confirmed allergy to walnut to participate in a food challenge of walnut syrup. The food challenge was performed by board-certified allergists and performed in the clinical research center at Cincinnati Children's Hospital Medical Center. The endpoints measured were objective or subjective evidence of an allergic reaction. RESULTS: Three samples of walnut syrup were obtained from three farms and submitted to The Institute of Agriculture and Natural Resources Food Allergy Research and Resources Program to assay for the walnut allergy protein. For all three samples, protein levels were below the limit of quantitation by ELISA. Nine individuals, average age 18.9 years, range 8-31 with documented walnut allergy had negative skin prick testing with walnut syrup, and completed a food challenge with no allergic reaction observed. CONCLUSIONS: Walnut syrup does not contain the allergenic protein causing allergies in individuals with a walnut allergy, and ingestion of the syrup does not lead to an allergic reaction.
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